Category: St. Jude Medical
St. Jude Medical says its preliminary results for the 4th quarter beat the high end of its prior forecast.
Medtronic suspends its worldwide renal denervation trials after the U.S. pivotal trial of its Symplicity device fails to meet its efficacy endpoint.
Medtronic (NYSE:MDT) said its Symplicty renal denervation device failed to meet the efficacy endpoint in a U.S. pivotal trial, Symplicity HTN-3, prompting it to suspend enrollment in its other Symplicity trials around the world and to say that a writedown of its renal denervation assets is likely.
Medtech titans and Minnesota rivals Medtronic and St. Jude Medical lands patents for a sheath steering system and an implantable medical device antenna.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Medtech titan St. Jude Medical gets an end-of-the-year boost, setting record highs day after day for nearly a week until peaking at $63.15 the day after Christmas.
Medical device giant St. Jude Medical (NYSE:STJ) ended 2013 with a boost, notching a new Wall Street high-water mark of $63.15 on December 26.
Medtronic plans to boost its footprint in Puerto Rico with a $6 million expansion that will bring 150 new jobs to the Isla del Encanto.
St. Jude Medical lands CE Mark approval in the European Union for a larger, 25mm version of its Portico replacement heart valve.
St. Jude Medical (NYSE:STJ) said it won CE Mark approval in the European Union for the 25mm version of its Portico replacement heart valve.